Abivax - ADR
ABVX
Get informed when a big investor buys or sells
+ FollowMarket Cap$6.69B
Close$
$7.77
91.5% downside
Current Fair Value
91.5% downsideOvervalued by 91.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $6.69 Billion |
|---|---|
| Enterprise Value | $6.30 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-4.65 |
| Beta | -0.25 |
| Outstanding Shares | 79,647,974 |
Return
| Return on Equity | -133.12% |
|---|---|
| Return on Assets | -105.49% |
| Return on Invested Capital | -104.99% |
Valuation & Multiples
| P/E Ratio | -17.39 |
|---|---|
| PEG | -105.26 |
| Price to Sales | - |
| Price to Book Ratio | 22.77 |
| Enterprise Value to Revenue | 3145.38 |
| Enterprise Value to EBIT | -15.37 |
| Enterprise Value to Net Income | -13 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
September 21, 2026
EPS Estimate
$-0.92
Average shareholder expectationRevenue Estimate
$799,166
Average shareholder expectationNext Earnings Call
Expected Date
December 21, 2026
EPS Estimate
$-1.27
Average shareholder expectationRevenue Estimate
$794,422
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.5354▼ 6.24% |
|---|---|
| Total Calls | 7,594,118▲ 310.50% |
| Total Puts | 4,065,944▲ 267.67% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 79.02%▲ 7.05% |
|---|---|
| Total Invested | $7.18B▲ 29.83% |
| Investors Holding | 367▲ 81.00% |
ESG Score
No data